Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry.

Bowers, Charles; Mytych, Daniel T; Lawrence, Tatiana; Wang, Kejia; Barger, Troy E; Eisen, Melissa; Bennett, Carolyn M; Tarantino, Michael D

Bowers, Charles; Mytych, Daniel T; Lawrence, Tatiana; Wang, Kejia; Barger, Troy E; Eisen, Melissa; Bennett, Carolyn M; Tarantino, Michael D.

Afiliação

Bowers C; Amgen Inc, Thousand Oaks, CA.
Mytych DT; Amgen Inc, Thousand Oaks, CA.
Lawrence T; Amgen Inc, Thousand Oaks, CA.
Wang K; Amgen Inc, Thousand Oaks, CA.
Barger TE; Amgen Inc, Thousand Oaks, CA.
Eisen M; Amgen Inc, Thousand Oaks, CA.
Bennett CM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA; and.
Tarantino MD; The Bleeding and Clotting Disorders Institute, University of Illinois College of Medicine-Peoria, Peoria, IL.

Blood Adv ; 5(23): 4969-4979, 2021 12 14.

Article em En | MEDLINE | ID: mdl-34638135

Assuntos

Receptores Fc; Trombopoetina; Anticorpos Neutralizantes; Criança; Ensaios Clínicos como Assunto; Humanos; Proteínas Recombinantes de Fusão; Sistema de Registros

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombopoetina / Receptores Fc Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombopoetina / Receptores Fc Idioma: En Ano de publicação: 2021 Tipo de documento: Article